Neurent Medical is pioneering innovative treatments for chronic inflammatory sino-nasal diseases by targeting and disrupting hyperactive autonomic nerves that drive the underlying inflammation. NEUROMARK is a gentle in-office treatment for chronic rhinitis, a common condition characterized by persistent symptoms of nasal congestion, nasal drainage, and numerous other symptoms that severely impact patient quality of life.
Location: Ireland, Athenry-Oranmore Municipal District, Oranmore
Employees: 11-50
Total raised: $25M
Founded date: 2015
Investors 2
Date | Name | Website |
01.03.2021 | Fountain H... | fh-partner... |
25.01.2021 | Life Scien... | lspvc.com |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
20.01.2021 | Series B | $25M | - | marketscre... |
Mentions in press and media 12
Date | Title | Description | Source |
13.11.2023 | Neurent Medical Announces New CPT Code® for Chronic Rhinit... | CMS Assignment Empowers ENT Physicians and Offers Relief to Millions of Chronic Rhinitis Patients ... | fh-partner... |
21.03.2023 | New Data show NEUROMARK® Chronic Rhinitis Treatment Offers... | Results from the CLARITY Study Show the NEUROMARK® System Provides Safe and Effective Treatment for ... | fh-partner... |
03.02.2023 | Neurent Medical Announces Limited Market Release of NEUROM... | NEUROMARK received new Category I CPT code and support from AAO position statement Neurent Medica... | fh-partner... |
18.11.2021 | Neurent Medical Receives FDA Clearance for NEUROMARK™, a N... | Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal di... | fh-partner... |
29.06.2021 | Neurent Medical Expands Leadership Team to Support Advance... | Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal di... | fh-partner... |
20.01.2021 | Neurent Medical Closes $25M Series B Funding | Neurent Medical, a Galway, Ireland-based company pioneering innovative treatments for chronic inflam... | finsmes.co... |
20.01.2021 | Neurent Medical Closes $25 Million Series B Funding to Advan... | GALWAY, Ireland -- Neurent Medical, a company pioneering innovative treatments for chronic inflammat... | abven.com/... |
20.01.2021 | Neurent Medical : Closes $25 Million Series B Funding to Adv... | Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal dise... | marketscre... |
09.07.2020 | EIT Health aids 11 start-ups disrupted by COVID-19 | EIT Health has awarded €5.5 million to start-ups in Europe to support with business continuity in re... | eithealth.... |
27.06.2019 | Brian Shields Named Founder Of The Year | Brian Shields from Neurent Medical has been named Founder of the Year 2019 at the Enterprise Ireland... | businesspl... |
Show more